On April 20, 2026, ViewsML Technologies Inc. announced that it closed $4.9 million in Series Seed equity funding to support the commercialization of its AI-powered platform.
The Vancouver-based startup is focused on helping clinicians and scientists analyze human tissue samples virtually, using AI to extract biomarker insights without the need for traditional lab processes. ViewsML’s Seed financing round was led by Wittington Ventures, with participation from Continuum Health Ventures and Mayo Clinic, alongside existing investors including RiSC Capital, Debiopharm, WUTIF Capital, Defined and eFund.
This financing will help scale the company’s virtual biomarker library, advance the development of clinical applications and support team growth across its engineering, scientific and commercial teams.
Osler, Hoskin & Harcourt LLP advised ViewsML Technologies Inc. with a team consisting of Mark Longo, Benjamin Miller and Rebecca Garner (Emerging and High Growth Companies).
Key Contact
Partner, Emerging and High Growth Companies, Vancouver
Team
Articling Student, admitted in California and New York, Vancouver
Associate, Emerging and High Growth Companies, Vancouver
